Refine by
Biopharmaceutical Analysis Articles & Analysis
9 news found
Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software, announced today a new partnership to advance glycoproteomics and biotherapeutics tools and research Macquarie University’s Analytical Glycoimmunology Group and Protein Metrics Inc. today have launched a strategic partnership scheme to further advance ...
Building on its years of experience, Creative Proteomics Pronalyse announces the launch of its metabolite identification services of biopharmaceuticals for an accurate and efficient analysis of the metabolism for your biological drugs in vivo. ...
Combining one of the world’s pre-eminent mass spectrometry platforms with best-in-class data analysis software helps biopharmaceutical organizations accelerate biotherapeutic drug development and enhance characterization capabilities that affect product quality, safety, and efficacy. ...
Intelligencia, whose AI-driven software platform enables pharmaceutical and biotechnology companies to revolutionize the drug development process and reduce risk, has raised $12M in order to continue to expand its product offering and customer base. Healthtech investor MTIP led the oversubscribed Series A round, joined by several of the company’s existing investors, including Big Pi ...
The companies will highlight the strengths of their technologies when coupled for protein analysis to provide laboratories with new and advanced biopharmaceutical capabilities that will enable greater insight into results generated by Imaged Capillary Isoelectric Focusing (iCIEF) protein separation. This will be of particular benefit to scientists working in the ...
Thermo Fisher Scientific, the world leader in serving science, and the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University, have entered into a collaborative agreement in a bid to advance analytical capabilities and drive innovation across the biopharmaceutical industry in areas including personalized medicine, ...
New York, NY – Jan. 4, 2019 – S1 Biopharma, Inc. (S1) announced today that researchers will present an expanded analysis of data from the company’s Phase 2a clinical trial of Lorexys™ for the treatment of women with hypoactive sexual desire disorder (HSDD) based on the Patient Global Impression of Change (PGIC) scale. Robert E. Pyke, MD, PhD, president of Pykonsult, LLC, ...
(NYSE: A) today announced new software releases designed to make research and development easier for scientists in the biopharmaceutical field. Enhancements to the company's industry-leading MassHunter BioConfirm and MassHunter Walkup products enable researchers to more easily focus on protein characterization, helping them obtain molecular weight, locate post-translational ...
Shimadzu Scientific Instruments has introduced an Aggregates Sizer Aggregation Analysis System, the first commercially available tool to provide real-time quantitative evaluation of 100nm to 10μm sub-visible particle (SVP) aggregates. ...